Directly compressed mini matrix tablets containing ibuprofen: Preparation and evaluation of sustained release

Drug Development and Industrial Pharmacy

Volumn 32, Issue 1, 2006, Pages 95-106

  Lopes, Carla M ^a   Manuel, José ^a   Lobo, Sousa ^a   Costa, Paulo ^a   Pinto, João F ^b  

^a UNIVERSITY OF PORTO   (Portugal)

^b RESEARCH INSTITUTE FOR MEDICINES IMED ULISBOA   (Portugal)

Author keywords

Ethylcellulose; HPMC; Ibuprofen; Mini matrix tablets; Sustained release

Indexed keywords

ETHYL CELLULOSE; HYDROXYPROPYLMETHYLCELLULOSE; IBUPROFEN; METHYLCELLULOSE; POLYMER;

ARTICLE; DRUG DIFFUSION; DRUG RELEASE; DRUG SCREENING; DRUG SYNTHESIS; MATRIX TABLET; SUSTAINED RELEASE FORMULATION; TABLET COMPRESSION; TABLET FORMULATION; VISCOSITY; WATER TRANSPORT;

CELLULOSE; DELAYED-ACTION PREPARATIONS; IBUPROFEN; METHYLCELLULOSE; SOLUBILITY; TABLETS; TECHNOLOGY, PHARMACEUTICAL; VISCOSITY;

EID: 32344433918     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.1080/03639040500388482     Document Type: Article

References (31)

1. Alderman, D. A. (1984). A review of cellulose ethers in hydrophilic matrices for oral controlled release dosage forms. Int. J. Pharm. Technol. Product Manuf., 5(3), 1-9.
2. Colombo, P., Conte, U., Caramella, C., Gazzaniga, A., & La Manna, A. (1985). Compressed polymeric mini-matrices for drug release control. J. Contr. Rel., 1(4), 283-289.
3. Colombo, P., Bettini, R., Santi, P., & Peppas, N. A. (2000). Swellable matrices for controlled drug delivery: gel-layer behavior, mechanisms and optima performance. PSTT, 3(6), 198-204.
4. Costa, P., & Sousa Lobo, J. M. (2001). Modelling and comparison of dissolution profiles. Eur. J. Pharm. Sci., 13(2), 123-133.
5. Cox, P. J., Khan, K. A., Munday, D. L., & Sujja-areevath, J. (1999). Development and evaluation of a multiple unit oral sustained release dosage form for S(+)ibuprofen: preparation and release kinetics. Int. J. Pharm., 193(1), 73-84.
6. De Brabander, C., Vervaet, C., Fiermans, L., & Remon, J. P. (2000a). Matrix mini-tablets based on starch/microcrystalline wax mixtures. Int. J. Pharm., 199(2), 195-203.
7. De Brabander, C., Vervaet, C., Gortz, J. P., Remon, J. P., & Berlo, J. A. (2000b). Bioavailability of ibuprofen from matrix mini-tablets based on a mixture of starch and microcrystalline wax. Int. J. Pharm., 208(1-2), 81-86.
8. De Brabander, C., Vervaet, C., & Remon, J. P. (2003). Development and evaluation of sustained release mini-matrices prepared via hot melt extrusion. J. Contr. Rel., 89(2), 235-247.
9. Desai, R. P., Neau, S. H., Pather, S. I., & Johnson, T. P. (2001). Fine-particle ethylcellulose as a tablet binder indirect compression, immediate-release tablets. Drug Dev. Ind. Pharm., 27(7), 633-641.
10. Donbrow, M., & Samuelov, Y. (1980). Zero order drug delivery from double-layered porous films: release rate profiles from ethyl cellulose, hydroxypropyl cellulose and polyethylene glycol mixtures. J. Pharm. Pharmacol., 32(7), 463-470.
11. Edgar, B., Bogentoft, C., & Lagerstrom, P. O. (1984). Comparison of two enteric-coated acetylsalicylic acid preparations by monitoring steady-state levels of salicylic acid and its metabolites in plasma and urine. Biopharm. Drug Dispos., 5(3), 251-260.
12. Ford, J., Rubinstein, M., & Hogan, J. (1985). Propranolol hydrochloride and aminophylline release from matrix tablets containing hydroxypropyl methylcellulose. Int. J. Pharm., 24(2-3), 339-350.
13. Graffner, C., Josefsson, K., & Stockman, O. (1986). Intra- and intersubject variation of erythromycin absorption from single unit and multiple unit enteric coated products. Biopharm. Drug Dispos., 7(2), 163-171.
14. Higuchi, T. (1961). Rate of release of medicaments from ointment bases containing drugs in suspension. J. Pharm. Sci., 50, 874-875.
15. Higuchi, T. (1963). Mechanism of sustained-action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J. Pharm. Sci., 52, 1145-1149.
16. Ho, H. O., Wang, H. Y., & Sheu, M. T. (1997). The evaluation of granulated excipients as matrix material for controlled delivery of captopril. J. Control. Rel., 49(2-3), 243-251.
17. Katikaneni, P. R., Upadrashta, S. M., Neau, S. H., & Mitra, A. K. (1995). Ethylcellulose matrix controlled release tablets of a water-soluble drug. Int. J. Pharm., 123(1), 119-125.
18. Kiil, S., & Dam-Johansen, K. (2003). Controlled drug delivery from swellable hydroxypropylmethylcellulose matrices: model-based analysis of observed radial front movements. J. Control. Rel., 90(1), 1-21.
19. Korsmeyer, R. W., Gurny, R., Doelker, E. M., Buri, P., & Peppas, N. A. (1983). Mechanism of solute release from porous hydrophilic polymers. Int. J. Pharm., 15(1), 25-35.
20. Lennartz, P., & Mielck, J. B. (1998). Minitabletting: improving the compactibility of paracetamol powder mixtures. Int. J. Pharm., 173(1-2), 75-85.
21. Papadimitriou, E., Buckton, G., & Efentakis, M. (1993). Probing the mechanisms of swelling of hydroxypropyl methylcellulose matrices. Int. J. Pharm., 98(1-3), 57-62.
22. Pather, S. I., Russel, I., Syce, J. A., & Neau, S. H. (1998). Sustained release theophylline tablets by direct compression, Part 1: formulation and in vitro testing. Int. J. Pharm., 164(1), 1-10.
23. Peppas, N. A. (1985). Analisys of fickian and non-fickian drug release from polymers. Pharm. Acta Helv., 60(4), 110-111.
24. Reddy, K. R., Mutalik, S., & Reddy, S. (2003). Once-daily sustained release-matrix tablets of nicorandil: formulation and in vitro evaluation. AAPS Pharm. Sci. Tech., 4(4), article 61 (www.aapspharmscitech.org).
25. Ritger, P. L., & Peppas, N. A. (1987). A simple equation for description of solute release. I. Fickian and non-Fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs. J. Contr. Rel., 5(1), 23-36.
26. Sadeghi, F., Ford, J. L., & Rajabi-Siahboomi, A. (2003). The influence of drug type on the release profiles from Surelease-coated pellets. Int. J. Pharm., 254(2), 123-135.
27. Sánchez-Lafuente, C., Faucci, M. T., Fernández- Arévalo, M., Álvarez-Fuentes, J., Rabasco, A. M., & Mura, P. (2002). Development of sustained release matrix tablets of didanosine containing methacrylic and ethylcellulose polymers. Int. J. Pharm., 234(1-2), 213-221.
28. Shaikh, N. A., Abidi, S. E., & Block, L. H. (1987). Evaluation of ethylcellulose matrix for prolonged release formulation, II. Sparingly water-soluble drugs: ibuprofen and indomethacin. Drug Dev. Ind. Pharm., 13(14), 2495-2518.
29. Siepmann, J., Kranz, H., Peppas, N. A., & Bodmeier, R. (2000). Calculation of the required size and shape of hydroxypropyl methylcellulose matrices to achieve desired drug release profiles. Int. J. Pharm., 201(2), 151-164.
30. Sujja-areevath, J., Munday, D. L., Cox, P. J., & Khan, K. A. (1998). Relationship between swelling, erosion and drug release in hydrophilic natural gum mini-matrix formulation. Eur. J. Pharm. Sci., 6(3), 207-217.
31. Upadrashta, S. M., Katikaneni, P. R., Hileman, G. A., & Keshary, P. R. (1993). Direct compression controlled release tablets using ethyl-cellulose matrices. Drug Dev. Ind. Pharm.,, 19(4), 449-460.